Source: EV Battery Tech.
  • EV Battery Tech (ACDC) has announced a private placement for gross proceeds of up to C$750,000
  • The company intends to allocate the proceeds toward general working capital and the completion of its acquisition of Optimal CP
  • Optimal CP provides clean and low-cost cryptocurrency mining infrastructure in North America
  • Extreme Vehicle Battery Technologies provides scalable, smart solutions for the electric vehicle and energy storage markets
  • EV Battery Tech (ACDC) is up by 14.29 per cent trading at $0.12 per share

EV Battery Tech (ACDC) has announced a private placement for gross proceeds of up to C$750,000.

The non-brokered placement is comprised of up to 37,750,000 units priced at $0.20 per unit.

Each unit consists of one common share and one common share purchase warrant.

Each warrant is exercisable into one common share priced at $0.25 for three years from the issuance date, subject to acceleration.

EV Battery intends to allocate the proceeds toward general working capital and the completion of its acquisition of Optimal CP, a company focused on the development and management of large-scale crypto mining facilities.

Extreme Vehicle Battery Technologies provides scalable, smart solutions for the electric vehicle and energy storage markets.

EV Battery Tech (ACDC) is up by 14.29 per cent trading at $0.12 per share as of 10:06 am EST.

More From The Market Online

Biotech company patenting world’s first AI voice test for substance abuse

Biotech company MindBio files a patent application for the world's first AI model to detect substance abuse though vocal analysis.

Big tech earnings week: AI’s moment of truth for record valuations

AI faces its ROI test, investors want profits, not just promises. Spending under scrutiny as massive AI capex must drive growth and margins.

Paramount and Blue Ant Media ink exclusive Canadian ad deal

Paramount names Blue Ant Media as its exclusive direct sales and programmatic partner for ads on Paramount+ and Pluto TV in Canada.

2 biotech stocks bridging the gap between unmet need and next-gen medicine

Exploring Lunai Bioworks and TheraCryf, two biotech stocks taking early strides towards improving the lives of tens of millions of patients.